INTRODUCTION
============

When evaluating and improving health care in chronic diseases, symptoms, function in daily life and well-being are important patient outcomes \[[@sfz084-B1]\]. Health-related quality of life (HRQoL) is a significant key indicator of how a condition affects the patient's life and HRQoL assessments can therefore identify possible problem areas related to health experiences. Interventions aimed at giving feedback and discussing the HRQoL outcomes face-to-face with the individual patient have been studied within oncology and diabetes care \[[@sfz084-B2], [@sfz084-B3]\]. Person-centered care and patient partnership have been increasingly highlighted as an important factor in improving health care quality \[[@sfz084-B4]\]. Patient-reported outcome measures (PROMs) have the potential to be a useful tool in achieving this.

PROMs embrace both symptoms and HRQoL, which are important measures in renal care. HRQoL refers to functioning and well-being in physical, mental and social dimensions of life as a subjective experience, which varies over time and illness trajectory \[[@sfz084-B5]\]. It is affected not only by health status and treatment, but also by factors like age, psychosocial aspects, culture, self-care ability, illness perception \[[@sfz084-B6]\] and care framing \[[@sfz084-B7], [@sfz084-B8]\].

Impaired HRQoL is well described among patients with chronic kidney disease (CKD) and found to correlate with factors such as symptom burden \[[@sfz084-B9]\], hypertension, anemia, nutritional status, dialysis modality, depression, cognitive dysfunction and frailty \[[@sfz084-B10]\], and also education, depression, exercise habits \[[@sfz084-B15]\], proteinuria \[[@sfz084-B16]\] and inflammatory status \[[@sfz084-B17]\]. Low HRQoL scores in dialysis patients have proved to be strong and independent predictors of hospitalization and mortality \[[@sfz084-B18]\]. Previous research has also shown that patients with a kidney transplant experience better HRQoL \[[@sfz084-B21], [@sfz084-B22]\], that deteriorating HRQoL is seen in early CKD stages \[[@sfz084-B15], [@sfz084-B23], [@sfz084-B24]\] and that the transition to commencing dialysis treatment has been identified as a vulnerable period with impaired HRQoL scores \[[@sfz084-B25], [@sfz084-B26]\]. Moreover, patients with CKD often suffer from comorbidities and complications such as cardiovascular disease and diabetes, which can be assumed to influence HRQoL.

Although PROMs are increasingly used in research, their use is still limited in routine care \[[@sfz084-B27]\]. Fundamental prerequisites for carrying out a systematic implementation of PROMs in clinical practice are appropriate measures; informed, trained and motivated staff; an implementation plan and a technical solution for electronic PROMs (ePROMs) online. In renal care, it is also of special interest to carry out assessments through the illness trajectory, that is, during the different CKD stages and renal replacement therapy (RRT) modalities.

This report describes the preparation, roll-out and initial results of PROM through the RAND 36-Item Health Survey (RAND-36), a PROM questionnaire assessing HRQoL, which was launched in 2017 by the Swedish Renal Registry (SRR) both online and as a conventional paper version for patients in renal care in Sweden.

MATERIALS AND METHODS
=====================

The SRR
-------

The SRR, started in 1991, is a national registry for renal failure. Today the SRR captures epidemiological information regarding renal care and outcomes from the entire disease trajectory starting with renal biopsies, continuing with CKD Stages 3--5 and on to RRT. Currently the SRR contains 13 000 patients with CKD Stages 3--5, 3200 patients on hemodialysis (HD), 900 on peritoneal dialysis (PD) and 5600 with a kidney transplant \[[@sfz084-B28]\]. Since the start \>65 000 patients have been registered. In Sweden, there are 68 units and departments providing specialized nephrology care and all 68 deliver data to the SRR. Recently the SRR decided to incorporate the RAND-36 PROM questionnaire into the registry, offering an opportunity for data collection online.

The RAND-36 questionnaire
-------------------------

The RAND-36 questionnaire was developed by the RAND Corporation. It is a self-administered generic HRQoL questionnaire that is not specific to any disease or treatment group. It is equivalent to the 36-item Short Form Health Survey (SF-36) questionnaire and covered by a conceptual model of HRQoL, measuring function and well-being \[[@sfz084-B29]\]. The questionnaire includes 36 items that yield an eight-dimensional profile measured on a 100-point scale; a higher score indicates a better perceived health state. The eight dimensions are physical functioning (PF), role limitations caused by physical problems role physical (RP), bodily pain (BP), general health (GH), vitality/energy/fatigue (VT), social functioning (SF), mental health/emotional well-being (MH) and role limitations caused by MH/emotional problems role emotional (RE). The items refer to perceived health status during the last 4 weeks. An additional item refers to the patient's assessment of his/her health transition (HT) during the last 24 months.

Mean scores of the SF-36 in a general Swedish population (*n* = 8930) 15--93 years of age are PF 87.9, RP 83.2, BP 74.8, GH 75.8, VT 68.8, SF 88.6, RE 85.7 and MH 80.9 \[[@sfz084-B30]\]. A validation of the Swedish version of the RAND-36, comprising dialysis patients, showed evidence supporting reliability as well as responsiveness \[[@sfz084-B31]\]. The algorithms for BP and GH differ between the RAND-36 and SF-36. However, these differences are negligible at the group level, which allows reliable comparisons of results from both questionnaires.

Launching ePROM in the SRR
--------------------------

The process of preparation and roll-out of the ePROM is described in [Table 1](#sfz084-T1){ref-type="table"}. This process included issues such as developing and testing the information technology (IT) solution, patient login for online PROM completion and an instant feedback graph ([Supplementary data](#sup1){ref-type="supplementary-material"}, [Figure S1](#sup1){ref-type="supplementary-material"}), pilot tests and interviews, drafting information packages to patients and medical staff and implementation activities. The SRR urged participating clinical units to ask all their patients to complete the questionnaire at least once a year.

###### 

Preparation and roll-out of ePROM in the SRR

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Choice of appropriate PROM for HRQoL in renal patients, given criteria like psychometric outcomes                                                                       Validation of the Swedish version of the RAND-36 in collaboration with the Swedish PROM center. Eighty-four dialysis patients from five clinics participated \[[@sfz084-B31]\]
  Development and pilot testing of the online version of the RAND-36 questionnaire                                                                                        Technically and legally secure and safe system for login and response procedures. Approved and tested IT solution with patient login through the SRR website or the Swedish National Health Guide System ('Vårdguiden 1177'). Pilot tests on 10 patients, including interviews, feedback on individual results, adjustments and retests
  Drafting patient information                                                                                                                                            Information package for clinical use on the SRR web page describing the questionnaire, response instructions, objectives, clinical use and responsible receiver
  Development and testing of feedback graph to patient and medical staff                                                                                                  The patient receives a feedback graph ([Supplementary data](#sup1){ref-type="supplementary-material"}, [Figure S1](#sup1){ref-type="supplementary-material"}) online instantly after completing the questionnaire. The graph describes the individual health profile together with explainatory text of the different health domains and index scores and can also be seen and used by medical staff
  Developing a technical solution for group-level outcome data in the SRR database                                                                                        Instant online results on request
  Implementation in clinical practice, information and education of medical staff within renal care about the motives, use and ways to handle the RAND-36 questionnaire   Continuous activities from the lead board of the SRR: workshops, presentations, professional meetings and discussions, articles in national renal periodicals, information package on the SRR homepage including materials like user's guide and guidelines for local implementation, checklists, information letter to managers, office support. Information to renal patients through the Swedish Kidney Patient Association. Collaboration with the Swedish Association of Renal Nurses
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Data collection
---------------

All renal clinics in Sweden (*n* = 68) were invited to implement and use the PROM via the SRR. Distribution of questionnaires, login information and collection of answers were organized by local nurses at each unit. The patients received a personal login that could be used on any computer, laptop, e-book reader or smartphone. They were asked to complete the questionnaire at the clinic or at home and they could opt between online or paper format, if that was considered more feasible. The flow chart of the ePROM roll-out is shown in [Figure 1](#sfz084-F1){ref-type="fig"}. PROM responses were extracted from the SRR database along with other relevant variables \[age, sex, estimated glomerular filtration rate (eGFR), treatment modality at the time of completion of the questionnaire\]. We selected the eGFR closest before the date of questionnaire completion.

![Flow chart for the PROM process.](sfz084f1){#sfz084-F1}

Statistical analysis
--------------------

Patient characteristics were described by means, medians and proportions according to their underlying distribution. The different domains of the RAND-36 were then assessed graphically and through descriptive statistics overall and stratified by age, sex and current treatment modality. Means and corresponding 95% confidence intervals were computed. Differences between groups were assessed by nonparametric statistics. All analyses were performed in Stata 15 (StataCorp, College Station, TX, USA).

Ethical considerations
----------------------

The study was approved by the Regional Ethical Review Board in Stockholm, Sweden. According to Swedish law, health care quality registries can be used for research. Patients have the right to opt out, but no additional individual consent is required for specific research projects.

RESULTS
=======

PROM implementation in clinical practice
----------------------------------------

The pilot tests showed that the patients had no technical problems with the online version and that it took between 3 and 10 min to complete the questionnaire online \[[@sfz084-B31]\]. The pilot interviews showed that the patients appreciated the feedback on their individual results online as well as by nursing staff. During the implementation phase, that is, the first year of use (2017), the RAND-36 questionnaire was completed by 1378 patients from 26/68 (39%) renal units. From HD units, 474/1220 (38.9%) patients completed the questionnaire; the proportion of patients from the 23 participating HD units varied from 1.8% to 97.6% ([Supplementary data](#sup1){ref-type="supplementary-material"}, [Table S1](#sup1){ref-type="supplementary-material"}). The response rate in the CKD, PD and transplant groups were not analyzed as the denominators for these groups were largely unknown.

PROM results
------------

The questionnaire was answered by 604 patients in CKD Stages 3--5, 474 patients on HD treatment, 237 patients with a kidney transplant and 63 patients on PD treatment ([Table 2](#sfz084-T2){ref-type="table"} and [Supplementary data](#sup1){ref-type="supplementary-material"}, [Table 2](#sfz084-T2){ref-type="table"}). About one-third (35.6%) of the participants were female, which is congruent with the overall proportion in the SRR. The mean age was 67.4 years; the transplant group was the youngest (58.3 years) and the CKD Stages 3--5 group was the oldest (70.8 years). Diabetes and cardiovascular disease were common among the participants. The mean eGFR in CKD patients not on dialysis (CKD-ND) was 23.3 mL/min/1.73 m^2^ and in the kidney transplant group was 44.1 mL/min/1.73 m^2^. Overall, the renal patient group showed an impaired health profile compared with that of the Swedish general population, especially regarding limitations related to physical problems, GH and VT ([Figure 2](#sfz084-F2){ref-type="fig"}).

![Unadjusted health domains (mean and confidence interval) of the RAND-36 in CKD (*n* = 1378, ages 21--93 years) and the SF-36 in the Swedish general population (*n* = 8930, ages 15≥80 years). PF: physical functioning; RP: role physical; BP: bodily pain; GH: general health; VT: vitality; SF: social functioning; RE: role emotional; MH: mental health; HT: health transition.](sfz084f2){#sfz084-F2}

###### 

Characteristics of participating patients

  Characteristics                                   Values
  ---------------------------------------------- -------------
  Sex                                            
   Women, *n* (%)                                 491 (35.6)
  Age (years), mean (SD)                         
   All participants (*n* = 1378)                  67.4 (14.4)
    CKD-ND (*n* = 604)                            70.8 (13.4)
    TX (*n* = 237)                                58.3 (12.3)
    HD (*n* = 474)                                67.6 (14.8)
    PD (*n* = 63)                                 68.1 (13.0)
  Age group (years), *n* (%)                     
   20--44                                          111 (8.1)
   45--64                                         383 (27.8)
   65--74                                         425 (30.8)
   ≥75                                            459 (33.3)
  Primary kidney disease, *n* (%)                
   Hypertension                                   307 (22.3)
   Other                                          258 (18.7)
   Glomerulonephritis                             247 (17.9)
   Diabetic nephropathy                           243 (17.6)
   Uremia unspecified                             163 (11.8)
   Polycystic kidney, adult type                   110 (8.0)
   Pyelonephritis                                  40 (2.9)
   Renal vascular disease                          10 (0.7)
  Comorbidity, *n* (%)                           
   Diabetes (*n* = 1349)                          402 (29.8)
   Ischemic heart disease (*n* = 1350)            229 (17.0)
   Heart disease, other (*n* = 927)               181 (19.5)
   Malignancy, except skin cancer (*n* = 1349)    145 (20.2)
   Cerebrovascular disease (*n* = 1350)            93 (6.9)
   Peripheral vessel (*n* = 1347)                  87 (6.5)
  eGFR (mL/min/1.73 m^2^), mean (SD)             
   CKD-ND (*n* = 574)                             23.3 (10.9)
   TX (*n* = 213)                                 44.1 (18.0)

CKD-ND: CKD not on RRT; TX: kidney transplant. eGFR, estimated glomerular filtration rate, ml/min/1.73 m^2^ by Modification of Diet in Renal Disease equation.

Treatment groups
----------------

When comparing the different patient groups, their health profiles differed, mainly within the areas of physical and emotional limitations ([Figure 3](#sfz084-F3){ref-type="fig"}). Transplanted patients assessed their HRQoL higher, whereas patients on dialysis treatment had the most impaired scores. However, in the HD group, 34.2% of the patients assessed their health as being improved compared with 1 year earlier, as compared with all other groups where the assessed health improvement ranged from 14% to 20%.

![Undajusted mean values RAND-36 health domains in treatment groups. CKD-ND (not on RRT): CKD Stages 3--5; TX: kidney transplant.](sfz084f3){#sfz084-F3}

Age groups
----------

When dividing the results in age groups, some differences emerged, especially regarding physical function and physical and emotional limitations ([Figure 4](#sfz084-F4){ref-type="fig"}). The youngest age group (ages 20--44 years) assessed their physical function higher and experienced fewer physical limitations and less BP than the other age groups. However, this age group also assessed their GH and their VT relatively low. In contrast, the oldest age group (≥75 years) demonstrated the lowest scores in five of the nine health areas (PF, RP, BP, RE, HT) but rated their MH higher than the other age groups. Comparisons between mean values of age groups in the SRR and the Swedish general population revealed that the older the patients, the smaller the difference compared with persons of the same age in the general population ([Supplementary data](#sup1){ref-type="supplementary-material"}, [Figure S2](#sup1){ref-type="supplementary-material"})

![Mean values of the RAND-36 health domains in age groups.](sfz084f4){#sfz084-F4}

DISCUSSION
==========

This description of a nationwide invitation to collect PROMs depicts the potential to assess HRQoL through a quality registry. The SRR, with its complete follow-up of patients from CKD Stages 3--5 through RRT offers a unique opportunity to follow the illness trajectory over time. It may be a valuable complement to other medical outcome measures. It also depicts the challenges in accomplishing a nationwide implementation and reveals the difficulties in collecting PROMs in routine care. A sample of 1378 of 22 710 patients was indeed low coverage, and the patient selection may have been biased. However, the distribution of age, sex, primary kidney disease and comorbidity did not differ much between responding patients on HD and all patients (responders and nonresponders) at participating HD units ([Supplementary data](#sup1){ref-type="supplementary-material"}, [Table S2](#sup1){ref-type="supplementary-material"}). To implement a new routine and to reach continuous and systematic data collection at all renal units is a substantial challenge. Despite facilitating actions to inform and incentivize staff, more and repeated efforts for training the staff are required to enhance implementation. Handling PROMs is new to most clinical units. Previous research indicates that concerns regarding routine use among clinicians need to be addressed for successful implementation \[[@sfz084-B32]\]. Factors contributing to engaging clinicians in the systematic use of PROMs have been identified as the use of a relevant, evidence-based and IT-supported questionnaire; a person-centered culture at the participating units; a systematic feedback approach to patients and active leadership and enthusiasm from respected clinicians \[[@sfz084-B33]\]. For successful implementation, clinical staff needs to understand and feel 'what's in it for me?' It is therefore important to underline motives and benefits like getting systematic knowledge about and follow-up of self-reported health and its relation to health care results and improvement; getting the opportunity to compare different patient and treatment groups; gaining a complementary perspective that contributes to a more holistic view and using a tool to highlight the patients' perspective and provide a starting point for a health dialogue that could contribute to increased patient participation and person-centered care. Besides analyzing the results from the RAND-36 at an aggregate level, it creates the potential to enable individual follow-up, including feedback dialogues, with the health care staff. This ensures the patient's perspective and participation and forms a basis for further care planning. In renal care---as in other chronic diseases---retaining or increasing HRQoL and well-being constitutes a care goal. Attention to the patients' HRQoL could facilitate accomplishing individually tailored interventions to enhance or maintain physical fitness/function and psychosocial well-being, as well as support self-management. Systematic implementation of monitoring and discussing HRQoL would not only facilitate communication and improve understanding of the patients' perspective in a more person-centered approach, but will also provide a tool to screen for and prioritize potential problems.

The online application has its pros and cons: the immediate feedback online was appreciated by the participating pilot patients. The online mode is time saving for the staff, as less time is required for manual registering tasks. On the other hand, not all patients have access to or feel comfortable with computers and the internet. Thus it is necessary to offer patients a paper questionnaire as well, if needed. However, as people are becoming more accustomed to utilizing electronic devices, we believe that the future of PROMs lies in the development of electronic medical records that will be automatically linked to ePROMs. This would enable caregivers, as well as patients, to look at the results at medical appointments and thus facilitate patient-centered care.

During this first year of implementation, 39% of all renal clinics participated. The response rate in the HD population was low, with a large variation between the participating units. A low response rate was also seen when implementing PROMs among HD patients within the SRR \[[@sfz084-B34]\], where the response rate initially was 29%. Clearly this highlights the challenge and the efforts needed to succeed in implementing new routines and systematic and nationwide collection of PROMs.

The patients investigated in this report had considerably lower scores compared with the Swedish general population. These results are in line with previous findings, that is, CKD has a negative impact on HRQoL, especially in the physical domains \[[@sfz084-B14], [@sfz084-B23]\]. The most affected HRQoL dimensions---limitations related to physical problems, GH and VT---require recognition and management. The transplant group, however, demonstrated higher scores. This is not surprising, since transplant is considered a favorable treatment, with fewer disturbances of well-being and everyday life. Previous findings also show that patients with a kidney transplant experience higher HRQoL scores \[[@sfz084-B21], [@sfz084-B22]\]. Our findings could also be explained by the facts that this may constitute a selected and younger group.

The dialysis groups showed impaired scores, especially in the role limitation domains (RP, RE). Besides assuming an impact from the kidney disease and treatment itself, it may also be partly explained by the fact that the treatment is time consuming. An interesting finding was that in the HD group, about a third of the patients reported that their health was improved during the last year. This may reflect that being stabilized and better treated for uremia in HD can improve HRQOL. It was earlier demonstrated that patients initiating dialysis had lower HRQoL scores, highlighting that the transitional state just before dialysis is started may be an exceptionally vulnerable time \[[@sfz084-B26]\]. However, it may also reflect that people experiencing better health are more prone to respond. In this report, the HD group seemed to be a bit better off than the PD group. This must be interpreted with caution, as the group sizes and age distribution differed and the PD group was rather small. Some studies indicate that PD treatment is related to better HRQoL \[[@sfz084-B35], [@sfz084-B36]\]. However, earlier reviews have found no difference between the two treatment groups \[[@sfz084-B37], [@sfz084-B38]\].

In our study, we also found some differences related to age. The youngest age group had higher scores on PF, physical limitations and pain, but had lower scores on GH and VT. The oldest age group had the lowest scores in several health domains but had higher scores than the other age groups in MH. These findings have been seen in earlier research \[[@sfz084-B39]\] and may be related to divergent health expectations and the ability to accept and adapt to impaired health \[[@sfz084-B40]\], where younger patients may have increased expectations of self-efficacy and a normal lifestyle. For the future and with more patient data, it would be interesting to analyze age differences within the treatment groups.

When interpreting any HRQoL instrument, one must consider its limitations. Ceiling and floor effects may skew the results. The individuals' assessment of their health status is subjective and affected by surrounding factors like cultural aspects and environmental changes, which should be considered when interpreting and comparing results \[[@sfz084-B41]\]. The group sizes of the patients versus the Swedish general population were disproportionate. Another considerable limitation was the low coverage. In this report, a nationwide, systematic procedure had not yet been reached. Besides implementation-related difficulties, nonresponse may have been due to frailty, cognitive function and language. At the time of this investigation, the SRR had access to the RAND-36 in only three languages, which also may have affected our results. Furthermore, another limitation is that data regarding the Swedish general population are somewhat out of date.

CONCLUSIONS
===========

The recently implemented PROM application in the SRR allows nationwide collection of HRQoL data in CKD patients. However, greater emphasis is needed in motivating clinical staff to embrace the tool and its possibilities in executing person-centered care. CKD patients demonstrated impaired HRQoL, especially regarding limitations related to physical problems, GH and VT. Initial results indicate that HRQoL differs between treatment modalities and age groups. With the challenges in collecting data kept in mind, we are still hopeful for future possibilities regarding PROMs through national quality registries.

Supplementary Material
======================

###### 

Click here for additional data file.
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